RTN/Nogo in forming Alzheimer's neuritic plaques

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 8, 2010, Pages 1201-1206

  Prior, Marguerite ^a   Shi, Qi ^a   Hu, Xiangyou ^a   He, Wanxia ^a   Levey, Allan ^b   Yan, Riqiang ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Axonal transport; BACE1; Barnes maze; Cognitive impairment; Dendritic spines; Dystrophic neurites; LTP; Neuritic plaques; Nogo; Reticulon; RTN3; RTN3 aggregates

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; NEUROFILAMENT PROTEIN; PROTEIN NOGO; SYNAPSIN I; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; COGNITIVE DEFECT; ENZYME ACTIVITY; GLIOSIS; HUMAN; NERVE CELL PLASTICITY; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENILE PLAQUE; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; ANIMALS; AXONS; CARRIER PROTEINS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MYELIN PROTEINS; NERVE TISSUE PROTEINS; PLAQUE, AMYLOID;

EID: 77954087430     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.01.017     Document Type: Review

References (53)

1. Anderson D.J., Hetzer M.W. Reshaping of the endoplasmic reticulum limits the rate for nuclear envelope formation. J. Cell Biol. 2008, 182:911-924.
2. Barnes C.A., Markowska A.L., Ingram D.K., Kametani H., Spangler E.L., Lemken V.J., Olton D.S. Acetyl-1-carnitine. 2. Effects on learning and memory performance of aged rats in simple and complex mazes. Neurobiol. Aging 1990, 11:499-506.
3. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997, 19:939-945.
4. Brunden K.R., Trojanowski J.Q., Lee V.M. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 2009, 8:783-793.
5. Cai Y., Saiyin H., Lin Q., Zhang P., Tang L., Pan X., Yu L. Identification of a new RTN3 transcript, RTN3-A1, and its distribution in adult mouse brain. Brain Res. Mol. Brain Res. 2005, 138:236-243.
6. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
7. di Scala F., Dupuis L., Gaiddon C., de Tapia M., Jokic N., Gonzalez de Aguilar J.L., Raul J.S., Ludes B., Loeffler J.P. Tissue specificity and regulation of the N-terminal diversity of reticulon 3. Biochem. J. 2005, 385:125-134.
8. Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001, 105:99-107.
9. Dodd D.A., Niederoest B., Bloechlinger S., Dupuis L., Loeffler J.P., Schwab M.E. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 2005, 280:12494-12502.
10. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120:885-890.
11. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000, 403:439-444.
12. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
13. Harrison K.D., Miao R.Q., Fernandez-Hernando C., Suarez Y., Davalos A., Sessa W.C. Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intracellular cholesterol trafficking. Cell Metab. 2009, 10:208-218.
14. He W., Lu Y., Qahwash I., Hu X.Y., Chang A., Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat. Med. 2004, 10:959-965.
15. He W., Hu X., Shi Q., Zhou X., Lu Y., Fisher C., Yan R. Mapping of interaction domains mediating binding between BACE1 and RTN/Nosgo proteins. J. Mol. Biol. 2006, 363:625-634.
16. He W., Shi Q., Hu X., Yan R. The membrane topology of RTN3 and its effect on binding of RTN3 to BACE1. J. Biol. Chem. 2007, 282:29144-29151.
17. Hu X., Shi Q., Zhou X., He W., Yi H., Yin X., Gearing M., Lev A., Yan R. Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J. 2007, 26:2755-2767.
18. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell Neurosci. 1999, 14:419-427.
19. Iwahashi J., Hamada N. Human reticulon 1-A and 1-B interact with a medium chain of the AP-2 adaptor complex. Cell Mol. Biol. 2003, (Noisy. -le-grand) 49 online pub: OL467-OL471.
20. Kiseleva E., Morozova K.N., Voeltz G.K., Allen T.D., Goldberg M.W. Reticulon 4a/NogoA locates to regions of high membrane curvature and may have a role in nuclear envelope growth. J. Struct. Biol. 2007, 160:224-235.
21. Kume H., Konishi Y., Murayama K.S., Kametani F., Araki W. Expression of reticulon 3 in Alzheimer's disease brain. Neuropathol. Appl. Neurobiol. 2009, 35:178-188.
22. Kume H., Murayama K.S., Araki W. The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1. J. Neurosci. Res. 2009, 13:2963-2972.
23. LaFerla F.M., Oddo S. Alzheimer's disease: abeta, tau and synaptic dysfunction. Trends Mol. Med. 2005, 11:170-176.
24. Lee J.K., Chan A.F., Luu S.M., Zhu Y., Ho C., Tessier-Lavigne M., Zheng B. Reassessment of corticospinal tract regeneration in Nogo-deficient mice. J. Neurosci. 2009, 29:8649-8654.
25. Lin X., Koelsch G., Wu S., Downs D., Dashti A., Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1456-1460.
26. Liu Y., Vidensky S., Ruggiero A.M., Maier S., Sitte H.H., Rothstein J.D. Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J. Biol. Chem. 2008, 283:6561-6571.
27. Murayama K.S., Kametani F., Saito S., Kume H., Akiyama H., Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur. J. Neurosci. 2006, 24:1237-1244.
28. Nicoll J.A., Barton E., Boche D., Neal J.W., Ferrer I., Thompson P., Vlachouli C., Wilkinson D., Bayer A., Games D., Seubert P., Schenk D., Holmes C. Abeta species removal after abeta42 immunization. J. Neuropathol. Exp. Neurol. 2006, 65:1040-1048.
29. Nziengui H., Bouhidel K., Pillon D., Der C., Marty F., Schoefs B. Reticulon-like proteins in Arabidopsis thaliana: structural organization and ER localization. FEBS Lett. 2007, 581:3356-3362.
30. Oddo S., Vasilevko V., Caccamo A., Kitazawa M., Cribbs D.H., LaFerla F.M. Reduction of soluble abeta and tau, but not soluble abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J. Biol. Chem. 2006, 281:39413-39423.
31. Oertle T., Schwab M.E. Nogo and its paRTNers. Trends Cell Biol. 2003, 13:187-194.
32. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K., Vallon R., Schwab M.E. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 2003, 23:5393-5406.
33. Onorato M., Mulvihill P., Connolly J., Galloway P., Whitehouse P., Perry G. Alteration of neuritic cytoarchitecture in Alzheimer disease. Prog. Clin. Biol. Res. 1989, 317:781-789.
34. Park J.H., Gimbel D.A., GrandPre T., Lee J.K., Kim J.E., Li W., Lee D.H., Strittmatter S.M. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J. Neurosci. 2006, 26:1386-1395.
35. Roebroek A.J., Ayoubi T.A., van de Velde H.J., Schoenmakers E.F., Pauli I.G., Van de Ven W.J. Genomic organization of the human NSP gene, prototype of a novel gene family encoding reticulons. Genomics 1996, 32:191-199.
36. Rosenzweig E.S., Barnes C.A. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog. Neurobiol. 2003, 69:143-179.
37. Selkoe D.J. Defining molecular targets to prevent Alzheimer disease. Arch. Neurol. 2005, 62:192-195.
38. Shi Q., Hu X., Prior M., Yan R. The occurrence of aging-dependent reticulon 3 immunoreactive dystrophic neurites decreases cognitive function. J. Neurosci. 2009, 29:5108-5115.
39. Shi Q., Prior M., He W., Tang X., Hu X., Yan R. Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites. J. Neurosci. 2009, 29:9163-9173.
40. Shibata Y., Voss C., Rist J.M., Hu J., Rapoport T.A., Prinz W.A., Voeltz G.K. The reticulon and DP1/Yop1p proteins form immobile oligomers in the tubular endoplasmic reticulum. J. Biol. Chem. 2008, 283:18892-18904.
41. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999, 402:537-540.
42. Steiner P., Kulangara K., Sarria J.C., Glauser L., Regazzi R., Hirling H. Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins. J. Neurochem. 2004, 89:569-580.
43. Tarawneh R., Holtzman D.M. Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention. CNS Neurol. Disord. Drug Targets 2009, 8:144-159.
44. Teter B., Ashford J.W. Neuroplasticity in Alzheimer's disease. J. Neurosci. Res. 2002, 70:402-437.
45. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
46. Vassar R., Kovacs D.M., Yan R., Wong P.C. The {beta}-secretase enzyme bace in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J. Neurosci. 2009, 29:12787-12794.
47. Voeltz G.K., Prinz W.A., Shibata Y., Rist J.M., Rapoport T.A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 2006, 124:573-586.
48. Wakana Y., Koyama S., Nakajima K., Hatsuzawa K., Nagahama M., Tani K., Hauri H.P., Melancon P., Tagaya M. Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and golgi. Biochem. Biophys. Res. Commun. 2005, 334:1198-1205.
49. Wojcik S., Engel W.K., Yan R., McFerrin J., Askanas V. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in AbetaPP-overexpressing cultured human muscle fibers. Acta Neuropathol. (Berl.) 2007, 114:517-526.
50. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999, 402:533-537.
51. Yan R., Shi Q., Hu X., Zhou X. Reticulon proteins: emerging players in neurodegenerative diseases. Cell Mol. Life Sci. 2006, 63:877-889.
52. Zhao X., Jantti J. Functional characterization of the trans-membrane domain interactions of the Sec61 protein translocation complex beta-subunit. BMC Cell Biol. 2009, 10:76.
53. Zhao J., Fu Y., Yasvoina M., Shao P., Hitt B., O'Connor T., Logan S., Maus E., Citron M., Berry R., Binder L., Vassar R. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 2007, 27:3639-3649.